Ultimovacs bags orphan drug tag for mesothelioma vaccine
Pharmaceutical Technology
OCTOBER 9, 2023
The FDA decision follows a similar designation for the vaccine UV1 against malignant melanoma in December 2021.
Pharmaceutical Technology
OCTOBER 9, 2023
The FDA decision follows a similar designation for the vaccine UV1 against malignant melanoma in December 2021.
PharmaShots
JUNE 16, 2023
Date: June 12, 2023 | Tags: Novartis, Chinook Therapeutics, Atrasentan, Zigakibart, BION-1301, IgA nephropathy, M&A, ~$3.5B Date: June 12, 2023 | Tags: Novartis, Chinook Therapeutics, Atrasentan, Zigakibart, BION-1301, IgA nephropathy, M&A, ~$3.5B
Let's personalize your content